Coherus Oncology, Inc. (CHRS)
1.59
+0.04
(+2.58%)
USD |
NASDAQ |
Jan 21, 12:49
Coherus Oncology Market Cap: 192.18M for Jan. 21, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Allogene Therapeutics, Inc. | 352.83M |
| MediciNova, Inc. | 82.07M |
| CorMedix, Inc. | 559.80M |
| Verastem, Inc. | 483.55M |
| Armata Pharmaceuticals, Inc. | 215.62M |
Market Cap Related Metrics
| PS Ratio | 2.205 |
| PEG Ratio | -1.064 |
| Price to Book Value | 2.189 |
| Price | 1.59 |
| Earnings Yield | -99.73% |
| PEGY Ratio | -1.064 |